Document library

Board of Retirement informational staff report (File 25-271.1) reporting $75M intended commitment to Kayne Anderson RE Partners VII (medical office, student housing, senior housing, light industrial) against $145M 2025 pacing plan; notes intent to propose European RE debt fund later in 2025.

Harrison Street Capital full GP presentation to VPIC for Real Estate Partners X, LP. The 71B AUM firm (Colliers 75% owned) exclusively focused on alternative real assets since 2005. Fund X targets $2B/$3B hard cap at 13-15% net IRR, continuing strategy of student housing, senior housing, healthcare delivery, life sciences, data centers and storage across North America and Europe.

RVK tear sheet for Harrison Street Real Estate Partners X, LP summarizing terms ($2B target/$3B hard cap, 13-15% net IRR target), track record across Funds I-IX, and strategy focused on demographic-driven needs-based alternative real estate (student housing, senior housing, healthcare, data centers, storage). First close targeted June/July 2025.

Meketa Investment Group due-diligence summary memo on Ventas Life Science and Healthcare Real Estate Fund (VLSHREF), evaluating the core+ open-end vehicle for ERSRI's core real estate allocation. Dated February 22, 2023.

ERSRI staff recommendation memo approving up to $25M commitment to Ventas Life Science and Healthcare Real Estate Fund (VLSHREF), a core/core+ open-end fund focused on life science, medical office, and seniors housing. Meeting date March 22, 2023.

Ventas manager presentation for Rhode Island SIC on the Ventas Life Science and Healthcare Real Estate Fund, a core/core+ open-end fund targeting life science, medical office, and seniors housing assets in top U.S. cluster markets.